In a move that signals a shift towards commercial growth and technological advancement, Cambridge-based biotechnology company Nuclera has announced significant changes to its leadership structure. The firm, known for its eProtein Discovery system – a benchtop platform designed to accelerate protein expression and purification workflows – has promoted three key executives to senior roles.
Paris-based AzurBio Pharma has officially launched, positioning itself as a strategic partner for biopharmaceutical companies seeking to bring innovative treatments to the European market. The company, founded by industry veteran Corinne Schmitz, aims to streamline the often complex process of European market entry, with a particular focus on rare and serious diseases with unmet medical […]
The merger of Calyx and Invicro has culminated in the launch of a new corporate entity, Perceptive, marking a significant development in the biopharmaceutical services sector. This rebranding reflects the organisation’s enhanced capabilities in providing comprehensive support throughout the drug development lifecycle.
Norgine, a prominent European specialty pharmaceutical and consumer healthcare company, has announced a significant leadership change with the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective 1 January 2025. This move comes as part of the company’s strategy to enhance its mission of delivering transformative medicines to patients and […]
A team of interdisciplinary researchers from the Fraunhofer-Gesellschaft has unveiled a new method for producing fine chemicals, including those used in pharmaceuticals, potentially transforming the traditionally complex and labour-intensive manufacturing process. The novel approach, modelled on a cascade system, allows multiple successive stages of synthesis to proceed without interruption, offering significant improvements in efficiency and […]
The Clinical Research Data Sharing Alliance (CRDSA) has released two new standards aimed at improving the sharing and reuse of anonymised individual patient data from clinical trials. The standards, published on 26 September 2024, seek to address common challenges faced by both data contributors and researchers in areas such as metadata, data completeness and utility.
New York-based researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to explore kinase-substrate interactions in human cellular systems. The portal, which aggregates data from multiple public databases, aims to provide the scientific community with a comprehensive platform for visualising and studying these interactions in systemwide […]
The Jackson Laboratory (JAX) in Maine, USA, has received a $1.6 million grant from the National Institutes of Health (NIH) to acquire a state-of-the-art mass spectrometry system. This new equipment, the Bruker timsTOF Ultra2, will significantly enhance the institution’s ability to conduct detailed analyses of proteins and metabolites at the single-cell level.
The FinnGen project, a large-scale Finnish research initiative in personalised medicine, has announced a collaboration with Azenta, Inc. to provide proteomics profiling for up to 20,000 individuals. This partnership aims to integrate proteomic insights with existing genomic data, with the aim advancing our understanding of complex diseases and paving the way for more targeted treatments.
Exothera, a GMP-certified contract development and manufacturing organisation (CDMO) specialising in viral vectors, RNA therapeutics, and vaccines, has announced the appointment of Cédric Volanti as its new Chief Executive Officer. The appointment, effective 8 October 2024, marks a significant milestone for the Belgian company as it seeks to strengthen its position in the biopharmaceutical manufacturing […]
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
